Severe Pulmonary Valve Regurgitation

1

Review clinical trials related to Severe Pulmonary Valve Regurgitation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Harmony TPV EMEA PMS

The Harmony Transcatheter Pulmonary Valve (TPV) System is indicated for use in the management of pediatric and adult congenital heart disease patients with severe pulmonary regurgitation (i.e., severe pulmonary regurgitation as determined by echocardiography and/or pulmonary regurgitant fraction ≥ 30% as determined by cardiac magnetic resonance imaging) who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for pulmonary valve replacement as judged by the medical team.

Participants needed: 80
Trial details
Biological sex: AllType: InterventionalSponsor: Medtronic CardiovascularUpdated: May 5, 2026Locations: 12
Eligibility criteria

Subject eligible to receive Harmony TPV System in conformity with Instructions f... [+1]

Obstruction of the central veins. [+10]